난포발달에 따른 M？llerian Inhibiting SubstanceType Ⅱ 수용체의 발현

키워드

참고문헌 (39)

1. Donahoe PK, "Mullerian inhibiting substance:a gonadal hormone with multiple functions", 14, pp.152~164 (1993)
2. Donahoe PK, "The hormonal control of testicular descent", 7, pp.270~283 (1986)
3. Powell SM, "Sex-specific fetal lung development and Mullerian inhibiting substance", 141, pp.466~470 (1990)
4. Douglas I, "An immunoassay to detect human Mullerian inhibiting substance in males and females during normal development", 70, pp.16~22 (1990)
5. Donahoe PK, "Mullerian inhibiting substance in humans:normal levels from infancy to adulthood", 81, pp.571~576 (1996)
6. Lee MM, "Mullerian inhibiting substance as a marker for ovarian sex cord tumor", 326, pp.466~471 (1992)
7. Josso N, "Pediatric applications of anti-Mullerian hormone research", 43, pp.243~248 (1995)
8. Lee MM, "Diagnostic utility of Mullerian inhibiting substance determination in patients with primary and recurrent granulosa cell tumors", 73, pp.51~55 (1999)
9. Cate RL, "Minimal antiproliferative effect of recombinant Mullerian inhibiting substance on gynecological tumor cell lines and tumor explants", 49, pp.2005~2011 (1989)
10. Masiakos PT, "Human ovarian cancer, cell lines, and primary ascites cells express the human Mullerian inhibiting substance (MIS) type II receptor, bind, and are responsive to MIS", 5, pp.3488~3499 (1999), a
11. Pearsall LA, "Highly purified Mullerian inhibiting substance inhibits human ovarian cancer in vivo", 8, pp.2640~2646 (2002)
12. Hudson PL, "Mullerian duct regression and antiproliferative bioactivities of Mullerian inhibiting substance reside in its carboxy- terminal domain", 131, pp.291~296 (1992)
13. Maheswaran S, "Mullerian inhibiting substance:an instructive developmental hormone with diagnostic and possible therapeutic applications", 22, pp.657~674 (2001)
14. di Clemente N, "Transduction pathway of anti-Mullerian hormone, a sex-specific member of the TGF-beta family", 14, pp.91~97 (2003)
15. van Leeuwen EC, "Anti-Mullerian hormone and anti-M llerian hormone type II receptor messenger ribonucleic acid expression in rat ovaries during postnatal development, the estrous cycle, and gonadotropin-induced follicle growth", 136, pp.4951~4962 (1995)
16. He WW, "Developmental expression of candidate Mullerian inhibiting substance type II receptor", 137, pp.160~165 (1996)
17. Ikawa H, "The ontogeny of Mullerian inhibiting substance in the gonads of the chicken", 16, pp.822~827 (1981)
18. LaQuaglia MP, "Detection of Mullerian inhibiting substance in biological samples by a solid phase sandwich radioimmunoassay", 118, pp.791~796 (1986)
19. Hayashi M, "The ontogeny of Mullerian inhibiting substance in granulosa cells of the bovine ovarian follicle", 35, pp.447~453 (1986)
20. Kuroda T, "Mullerian inhibiting substance in the adult rat ovary during various stages of the estrous cycle", 125, pp.1060~1066 (1989)
21. He WW, "Mullerian inhibiting substance messenger ribonucleic acid expression in granulosa and Sertoli cells coincides with their mitotic activity", 131, pp.854~862 (1992)
22. Mattaliano RJ, "Isolation of the bovine and human gene for Mullerian inhibiting substance and expression of the human gene in animal cells", 45, pp.685~698 (1986)
23. Koide SS, "Mullerian inhibiting substance as oocyte meiosis inhibitor", 47, pp.225~234 (1986)
24. Cook C, "Mullerian inhibiting subatance in follicular fluid and serum: a comparison of patients with tubal factor infertility, polycystic ovary syndrome, and endometriosis", 67, pp.962~965 (1997)
25. Seibel MM, "The inhibitory effects of Mullerian inhibiting substance on epidermal growth factor induced proliferation and progesterone production of human granulosa-luteal cells", 75, pp.911~917 (1992)
26. Goxe B, "Inhibitory effect of anti-Mullerian hormone upon the expression of aromatase and LH receptors by cultured granulosa cells of rat and porcine immature ovaries", 2, pp.553~558 (1994)
27. Lee MM, "Mullerian inhibiting substance production and cleavage is modulated by goandotropins and steriods", 129, pp.2985~2992 (1991)
28. Faure E, "Insensitivity to anti-Mullerian hormone due to a mutation in the human anti-Mullerian hormone receptor", 11, pp.382~388 (1995)
29. Chen YG, "Engagement of bone morphogenetic protein type IB receptor and Smad1 signaling by anti-Mullerian hormone and its type II receptor", 275, pp.27973~27978 (2000)
30. Yi SE, "M llerian inhibiting substance signaling uses a bone morphogenetic protein (BMP)-like pathway mediated by ALK2 and induces Smad6 expression", 15, pp.946~959 (2001)
31. Olaso R, "The serine", threonine transmembrane receptor ALK2 mediates Mullerian inhibiting substance signaling, 2001, pp.15, 936~945
32. Adin P, "Molecular mechanisms of hormone-mediated Mullerian duct regression:involvement of β-catenin", 127, pp.3349~3360 (2000)
33. Ha TU, "M llerian inhibiting substance inhibits breast cancer cell growth through an NFkB-mediated pathway", 275, pp.28371~28379 (2000)
34. Segev DL, "Mullerian inhibiting substance inhibits ovarian cell growth through an Rb-independent mechanism", 275, pp.37101~37109 (2000)
35. Hsueh AJ, "Initial and cyclic recruitment of ovarian follicles", 21, pp.200~214 (2000)
36. 김미란, "난소에서 M llerian inhibiting substance의 발현", 40, pp.524~530 (1997)
37. Gruijters MJ, "Anti-Mullerian hormone inhibits initiation of primordial follicle growth in the mouse ovary", 143, pp.1076~1084 (2002)
38. MacLaughlin DT, "Gonadotropin-releasing hormone agonist-induced differences in granulosa cell cycle kinetics are associated with alterations in follicular fluid Mullerian-inhibiting substance and androgen content", 76, pp.711~714 (1993)
39. Whitelaw PF, "Developmental regulation of androgen receptor in rat ovary", 145, pp.533~543 (1995)

관련 논문AI추천